Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma

Histopathology

Volumn 63, Issue 6, 2013, Pages 841-851

  Chatterjee, Deyali ^a   Katz, Matthew H ^a   Rashid, Asif ^a   Estrella, Jeannelyn S ^a   Wang, Hua ^a   Varadhachary, Gauri R ^a   Wolff, Robert A ^a   Lee, Jeffrey E ^a   Pisters, Peter W ^a   Abbruzzese, James L ^a   Fleming, Jason B ^a   Wang, Huamin ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Fibrosis; Inflammation; Islet cell aggregation; Neoadjuvant therapy; Neuroma like nerve proliferation; Pancreatic cancer; Pancreatic intraepithelial neoplasia

Indexed keywords

EOSIN; HEMATOXYLIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL AGGREGATION; CELL PROLIFERATION; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; NEUROMA; PANCREAS ADENOCARCINOMA; PANCREAS ADENOMA; PANCREAS ISLET CELL; PANCREATICODUODENECTOMY; PANCREATITIS; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; STAIN;

FIBROSIS; INFLAMMATION; ISLET CELL AGGREGATION; NEOADJUVANT THERAPY; NEUROMA-LIKE NERVE PROLIFERATION; PANCREATIC CANCER; PANCREATIC INTRAEPITHELIAL NEOPLASIA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; CELL AGGREGATION; CELL PROLIFERATION; FEMALE; FIBROSIS; HUMANS; INFLAMMATION; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NERVOUS SYSTEM; PANCREAS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; YOUNG ADULT;

EID: 84887827819     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12234     Document Type: Article

References (39)

1. Alberts SR, Gores GJ, Kim GP et al. Treatment options for hepatobiliary and pancreatic cancer. Mayo Clin. Proc. 2007; 82; 628-637.
2. Desai S, Ben-Josef E, Griffith KA et al. Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancer. Int. J. Radiat. Oncol. Biol. Phys. 2009; 75; 1450-1455.
3. Picozzi VJ, Kozarek RA, Traverso LW. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am. J. Surg. 2003; 185; 476-480.
4. Regine WF, Winter KA, Abrams RA et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA 2008; 299; 1019-1026.
5. Garcea G, Dennison AR, Pattenden CJ, Neal CP, Sutton CD, Berry DP. Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP 2008; 9; 99-132.
6. Evans DB, Varadhachary GR, Crane CH et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J. Clin. Oncol. 2008; 26; 3496-3502.
7. Le Scodan R, Mornex F, Girard N et al. Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review. Ann. Oncol. 2009; 20; 1387-1396.
8. Meszoely IM, Wang H, Hoffman JP. Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: the Fox Chase Cancer Center experience, 1986-2003. Surg. Oncol. Clin. North Am. 2004; 13; 685-696, x.
9. Turrini O, Viret F, Moureau-Zabotto L et al. Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten-year single institution experience. Oncology 2009; 76; 413-419.
10. Varadhachary GR, Wolff RA, Crane CH et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J. Clin. Oncol. 2008; 26; 3487-3495.
11. Moutardier V, Magnin V, Turrini O et al. Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2004; 60; 437-443.
12. Roy R, Maraveyas A. Chemoradiation in pancreatic adenocarcinoma: a literature review. Oncologist 2010; 15; 259-269.
13. Snady H, Bruckner H, Cooperman A, Paradiso J, Kiefer L. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Cancer 2000; 89; 314-327.
14. Chatterjee D, Katz MH, Rashid A et al. Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome. Cancer 2012; 118; 3182-3190.
15. Chatterjee D, Katz MH, Rashid A et al. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am. J. Surg. Pathol. 2012; 36; 409-417.
16. Chatterjee D, Rashid A, Wang H et al. Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy. Am. J. Surg. Pathol. 2012; 36; 552-559.
17. Estrella JS, Rashid A, Fleming JB et al. Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. Cancer 2012; 118; 268-277.
18. Wang J, Estrella JS, Peng L et al. Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Cancer 2012; 118; 3801-3811.
19. Zhao Q, Rashid A, Gong Y et al. Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis. Ann. Diagn. Pathol. 2012; 16; 29-37.
20. Varadhachary GR, Tamm EP, Abbruzzese JL et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann. Surg. Oncol. 2006; 13; 1035-1046.
21. Haugk B. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer? Histopathology 2010; 57; 503-514.
22. vanGeenen EJ, Smits MM, Schreuder TC, van der Peet DL, Bloemena E, Mulder CJ. Smoking is related to pancreatic fibrosis in humans. Am. J. Gastroenterol. 2011; 106; 1161-1166; quiz 1167.
23. Wang Y, Sternfeld L, Yang F et al. Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells. Gut 2009; 58; 422-430.
24. Andea A, Sarkar F, Adsay VN. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod. Pathol. 2003; 16; 996-1006.
25. Hruban RH, Takaori K, Klimstra DS et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am. J. Surg. Pathol. 2004; 28; 977-987.
26. Hruban RH, Maitra A, Goggins M. Update on pancreatic intraepithelial neoplasia. Int. J. Clin. Exp. Pathol. 2008; 1; 306-316.
27. Delpu Y, Hanoun N, Lulka H et al. Genetic and epigenetic alterations in pancreatic carcinogenesis. Curr. Genomics 2011; 12; 15-24.
28. Recavarren C, Labow DM, Liang J et al. Histologic characteristics of pancreatic intraepithelial neoplasia associated with different pancreatic lesions. Hum. Pathol. 2011; 42; 18-24.
29. Ammann RW, Heitz PU, Kloppel G. Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology 1996; 111; 224-231.
30. Chong AK, Hawes RH, Hoffman BJ, Adams DB, Lewin DN, Romagnuolo J. Diagnostic performance of EUS for chronic pancreatitis: a comparison with histopathology. Gastrointest. Endosc. 2007; 65; 808-814.
31. Albashir S, Bronner MP, Parsi MA, Walsh RM, Stevens T. Endoscopic ultrasound, secretin endoscopic pancreatic function test, and histology: correlation in chronic pancreatitis. Am. J. Gastroenterol. 2010; 105; 2498-2503.
32. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat. Rev. Cancer 2003; 3; 276-285.
33. Ling J, Kang Y, Zhao R et al. Krasg12d-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 2012; 21; 105-120.
34. Shia J, Guillem JG, Moore HG et al. Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am. J. Surg. Pathol. 2004; 28; 215-223.
35. Friess H, Shrikhande S, Shrikhande M et al. Neural alterations in surgical stage chronic pancreatitis are independent of the underlying aetiology. Gut 2002; 50; 682-686.
36. Bockman DE, Buchler M, Malfertheiner P, Beger HG. Analysis of nerves in chronic pancreatitis. Gastroenterology 1988; 94; 1459-1469.
37. Ceyhan GO, Bergmann F, Kadihasanoglu M et al. Pancreatic neuropathy and neuropathic pain-a comprehensive pathomorphological study of 546 cases. Gastroenterology 2009; 136; 177-186.
38. Matsukuma S, Sato K. Pancreatic neuroma-like lesions after upper abdominal surgery: a clinicopathological postmortem study. Virchows Arch. 2010; 457; 651-657.
39. Ceyhan GO, Demir IE, Maak M, Friess H. Fate of nerves in chronic pancreatitis: neural remodeling and pancreatic neuropathy. Best Pract. Res. Clin. Gastroenterol. 2010; 24; 311-322.